Devrim ÖZER, Yavuz ARIKAN, Volkan GUR, Cantay GÖK, Yunus Emre AKMAN

Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment

Objective: Chondroblastoma is a benign aggressive tumor which needs surgical treatment and has a recurrence rate up to 35%. Extended (aggressive) curettage is the mainstay of treatment and local adjuvants have been reported to decrease the recurrence rate. Methods: The recurrence rates and the functional results of 14 patients who were treated in our institution and 2 other patients who were treated elsewhere between the years 2004e2016 were evaluated. Seventeen cases (13 male, 3 female; mean age: 17.1 [range: 13 to 32] years) who had been diagnosed, treated and followed up in our hospital between 2004 and 2016 were evaluated in terms of recurrence rates and functional outcomes. The average follow-up period was 41.6 (range: 12 to 132) months. Results: Five cases of recurrence were observed. Two cases had undergone their primary treatment in another institution. Seven cases were performed curettage alone whereas nine others were administered adjuvant treatments. One of the five recurrence patients was advised to undergo disarticulation. Another was treated with curettage and grafting and the remaining three patients with curettage and cementing. No recurrence was observed in their follow-up period. Their mean MSTS score was 27.3 (range: 4 to 30) over a maximum of 30 points and their functional results were good. Conclusion: Chondroblastoma is a tumor with high recurrence rates in the post-treatment period. However, good functional outcomes can be achieved with early diagnosis and appropriate treatment even after recurrence.

___

Benign Chondroblastoma. In: Unni KK, Invards CY, eds. Dahlin's Bone Tumors. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2010. Ch 4:41.

Xu H, Nugent D, Monforte HL, et al. Chondroblastoma of bone in the extremites: a multicenter retrospective study. J Bone Joint Surg Am. 2015;97(11):925e931.

Kurt AM, Unni KK, Sim FH, Mcleod RA. Chondroblastoma. Hum Path. 1989;24(9):944e949.

Suneja R, Grimer RJ, Belthur M, et al. Chondroblastoma of bone: long term results and functional outcome after intralesional currtage. J Bone Joint Surg Br. 2005;87(7):974e978.

Resnick D, Kyriakos M, Greenway GD. Tumors and Tumor like lesions of bone. In: Resnick D, Kransdorf MJ, eds. Bone and Joint Imaging. 3rd ed. Philadelphia: Elseiver Saunders; 2005. Ch 70: 1120.

Chondrogenic lesions. In: Greenspan A, Jundt G, Remagon W, eds. Differantial Diagnosis in Orthopedic Oncology. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2007. Ch 3,158.

Farfalli GL, Slullitel PA, Musculo DL, Ayerza MA, Aponte - Tinao LA. What happens to the articular surface after curettage for epiphyseal chondroblastoma ? A report on functional results , arthritis and arthroplasty. Clin Orthop Relat Res. 2017;475(3):760e766.

Marshhour MA, Abdel Rahman M. Lower recurrencerate in chondroblastoma using extended curettage and crysurgery. Int Orthop. 2014;38(5):1019e1024.

Atalar H, Basarir K, Yildiz Y, Erekul S, Saglik Y. Management of Chondroblastoma : retrospective review of 28 patients. J Orthop Sci. 2007;12(4): 334e340.

Cho HS, Park YK, Oh JH, LeeJ H, Han I, Kim HS. Proksimal tibia chondroblastoma treated with curretage and bone graft and cement use. Orthopedics. 2016;39(1):80e85.

Heck Jr RK. Benign aggressive tumors of bone. In: Canale ST, Beaty JH, eds. Campbell's Operative Orthopaedics. 12th ed. Philadelphia: Elsevier Mosby; 2013. Ch 26,887.

Springfield DS, Capanna R, Gherlinzoni F, Picci P, Campanacci M. Chondroblastoma:a review of seventy cases. J Bone Joint Surg Am. 1985;67(5):748e755.

Tiefenboeck TM, Stockhammer V, Panatopoulos J, et al. Complete local tumor control after curettage of Chondroblastoma-a retrospective analysis. Orthopaedic Traumatology Surg Res. 2016;102(4):473e478.

Mittag F, Leichtle C, Kieckbusch I, et al. Cytotoxic effect and tissue penetration of phenol for adjuvant treatment of Giant cell tumors. Oncol Lett. 2013;5(5): 1595e1598.

Lehner B, Witte D, Weiss S. Clinical and radiological long-term results after operative treatment of chondroblastoma. Arch Orthop Trauma Surg. 2011;131(1):45e52.

Wallace MT, Henshaw RM. Results of cement versus bone gtaft reconstruction after intralesional curettage of bone tumors in the skeletally immature patient. J Pediatr Orthop. 2014;34(1):92e100.

Gaston CL, Tilmann RM, Grimer RJ. Distal femoral growth arrest secondary to a cemented proximal femoral endoprosthetic replacement. J Bone Joint Surg Br. 2011;93(5):708e710.

Ganz R, Gill TJ, Gautier E. Surgical dislocation of adult hip:a technique with full access to the femoral head and acetabulum without the risk of avascular necrosis. J Bone Joint Surg Br. 2001;83(8):1119e1124.

Rajalakshmi R, Srivastava DN, Rastagi S, Julka PK, Bhatnagar S, Gamanagatti S. Bipolar radiofrequency ablation of tibial chondroblastomas : a report of three cases. World J Radiol. 2012;4(7):335e340.

Rybak LD1, Rosenthal DI, Wittig JC. Chondroblastoma: radiofrequency ablation–alternative to surgical resection in selected cases. Radiology. 2009;251(2): 599e604.

Cho HS, Park YK, Oh JH, Lee JH, Han I, Kim HS. Proksimal Tibial chondroblastoma treated with curettage and bone graft and cement use. Orthopaedics. 2016;39(1):80e85.

Sohn SH1, Koh SA, Kim DG, et al. A case of spine origin chondroblastoma metastasis to lung. Cancer Res Treat. 2009 Dec;41(4):241e244.